Back to Search
Start Over
BioCryst presents evidence on high adherence, persistence rates with ORLADEYO
- Source :
- The Fly. October 24, 2024
- Publication Year :
- 2024
-
Abstract
- BioCryst Pharmaceuticals announced new real-world comparative research on the use of oral, once-daily ORLADEYO that found high rates of adherence and persistence for ORLADEYO, similar to the rates observed with [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.813431797